pillbase.ru

Ebymect

Active substance: dapagliflozin propanediol monohydrate, metformin hydrochloride

dapagliflozin propanediol monohydrate, metformin hydrochloride

Centralised EU authorisationActive

Marketing holder: AstraZeneca AB

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing dapagliflozin propanediol in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 19
  • DAPAGLIFLOZIN
    TABLET, FILM COATED · DAPAGLIFLOZIN PROPANEDIOL 10 mg/1
    50090-7057
    A-S Medication Solutions
  • DAPAGLIFLOZIN
    TABLET, FILM COATED · DAPAGLIFLOZIN PROPANEDIOL 10 mg/1
    63629-3253
    Bryant Ranch Prepack
  • DAPAGLIFLOZIN
    TABLET, FILM COATED · DAPAGLIFLOZIN PROPANEDIOL 5 mg/1
    69097-388
    Cipla USA Inc.
  • DAPAGLIFLOZIN
    TABLET, FILM COATED · DAPAGLIFLOZIN PROPANEDIOL 5 mg/1
    50090-7056
    A-S Medication Solutions
  • DAPAGLIFLOZIN
    TABLET, FILM COATED · DAPAGLIFLOZIN PROPANEDIOL 10 mg/1
    66993-457
    Prasco Laboratories
All products in this country (19)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-57f4-7e7c-ad97-0f99009ecb82,01a1208e-5ca0-79a2-b358-dcfac8eb1f39,01a1208e-a9a1-7bb9-9462-9fdfbb3589ea,01a1208e-aad0-7a55-8e60-91e2839e6490,01a1208f-c398-716a-9ba6-ef910f22aa8e;count=12 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004162
Registration status
Active
ATC code
A10BD15
Sources
  • product · EMA · EMEA/H/C/004162 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004162 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004162 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/004162 · Verified 2026-10-09